Investing.com - H.C. Wainwright重申对Microbot Medical(纳斯达克股票代码:MBOT)的买入评级和$12.00的目标价,此前该公司宣布在美国全面上市。该股目前交易价格为$2.35,市值为1.5782亿美元,年初至今上涨17.5%。 Microbot Medical周一宣布,公司已成功完成LIBERTY系统的有限市场发布,并将于2026年4月11-15日在 ...

马萨诸塞州欣厄姆 - Microbot Medical Inc. (NASDAQ:MBOT)周一宣布,将在4月13日至16日举行的第25届Needham年度虚拟医疗保健会议上发表演讲。 首席执行官、总裁兼董事长Harel ...

Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced that it will highlight recent commercial achievements leading to the ...

Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced today that it has successfully executed its limited market release ...

Microbot Medical (Nasdaq:MBOT) today announced the full market release of its Liberty endovascular surgical robot in the U.S.

HINGHAM, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced today that the ...

Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced that it will highlight recent commercial ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Microbot Medical ( (MBOT)) has issued an announcement. Microbot Medical Inc. has amended and is utilizing its existing at-the-market equity offering program with H.C. Wainwright & Co., allowing it to ...

Microbot Medical Inc. announced that it has executed a limited market release of the Liberty robotic system for peripheral ...

Being Published in the Journal of Vascular and Interventional Radiology, a Premier Peer-Reviewed Journal, Speaks to the Quality and Impact of the Study Company Remains Focused on Expanding ...